Skip to content

Non-Invasive Diagnostic and Functional Evaluation of Cardiac Involvement in Patients With Systemic Sclerosis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00453752
Enrollment
100
Registered
2007-03-29
Start date
2006-04-30
Completion date
2010-04-30
Last updated
2007-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Sclerosis

Keywords

systemic sclerosis, pulmonary hypertension, echocardiography, N-Terminal proBNP

Brief summary

The aim of this study was to assess serum N-terminal proBNP (NT-proBNP) in systemic sclerosis patients and to establish whether it reflects the severity of RV overload.

Detailed description

Elevated serum brain natriuretic peptide (BNP) levels released from myocytes of ventricles upon stretch have been found in patients with isolated right ventricular (RV) pressure overload. However, limited data suggest that serum BNP may be elevated in patients with systemic sclerosis (SSc), especially with RV dysfunction. The aim of this study was to assess serum N-terminal proBNP (NT-proBNP) in SSc patients and to establish whether it reflects the severity of RV overload.

Interventions

None listed

Sponsors

Medical University of Warsaw
Lead SponsorOTHER

Study design

Observational model
DEFINED_POPULATION
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Clinical diagnosis of systemic sclerosis

Exclusion criteria

* Cardiovascular disorders other than pulmonary hypertension * Significant pulmonary function abnormalities * Impaired renal function

Countries

Poland

Contacts

Primary ContactCiurzyński Michał, M.D, Ph.D
mciurzyn@amwaw.edu.pl+48 22 502 11 44
Backup ContactPiotr Pruszczyk, M.D, Ph.D.
ppruszczyk@amwaw.edu.pl+48 22 501 11 44

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026